South Korea's Ministry of Food and Drug Safety is moving to close a regulatory gap that's let nicotine-like substances bypass the country's vape rules — a loophole that matters for anyone selling or using nicotine pouches with alternative alkaloids.

The ministry plans to finish a safety assessment of 6-methylnicotine by the end of this year, per Tobacco Reporter. It's also examining other nicotine-imitation substances that currently fall outside Korea's existing nicotine product framework.

Why This Matters for Pouches

6-methylnicotine is a tobacco alkaloid structurally similar to nicotine but not identical — which has allowed some manufacturers to market products containing it without meeting the same regulatory requirements as standard nicotine products. In Korea's case, the substance has been used in vaping products that evade classification under current rules.

For the pouch market, the precedent is clear: if Korea decides 6-methylnicotine requires the same controls as nicotine, any pouches using the compound would face the same restrictions. That includes age verification, health warnings, and potentially flavor or marketing limits.

The ministry's broader look at "nicotine-imitation substances" suggests this won't be a one-time fix. As brands experiment with alkaloid alternatives — whether to dodge regulation or differentiate products — regulators are catching up.

What Happens Next

Korea's assessment timeline means a decision is coming within months. If 6-methylnicotine gets classified as equivalent to nicotine for regulatory purposes, any products on Korean shelves will need to comply or exit.

The move mirrors regulatory tightening elsewhere: the EU has debated synthetic nicotine rules, and the U.S. FDA has made clear that nicotine analogs don't escape tobacco product oversight. Korea's action adds another jurisdiction where "nicotine-like" won't mean "regulation-free."

SOURCES:

• Tobacco Reporter: Nicotine-Like Products Expose Blind Spot in Korean Vape Rules